Catalyst Wire Dossier Catalyst Wire Dossier

Mesothelin-targeted CAR T-cell therapy

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Mesothelin-targeted CAR T-cell therapy, covering 2025-07-25 to 2026-02-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer [Phase 1]

See pricing